Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

ClinicalTrials.gov public records Last synced May 22, 2026, 1:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–26 of 2 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: AMS Clear all

Withdrawn Not applicable Interventional

RETINA IMPLANT Alpha AMS in Blind Patients With Retinitis Pigmentosa

NCT03629899

View directory record Official record

Conditions: Retinitis Pigmentosa
Interventions: RETINA IMPLANT Alpha AMS; Device
Lead sponsor: Wills Eye; Other
Eligibility: 50 Years and older

Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Source: ClinicalTrials.gov public record

Updated May 9, 2019 · Synced May 22, 2026, 1:09 AM EDT

Completed Phase 1 Interventional

Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

NCT01463046

View directory record Official record

Conditions: Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome
Interventions: Panobinostat, Cytarabine, Daunorubicin; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older

Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: San Francisco, California

Source: ClinicalTrials.gov public record

Updated Apr 21, 2019 · Synced May 22, 2026, 1:09 AM EDT